A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

计划入组 73 人 · 首次发布于 2022 年 7 月 12 日

Partners at Meals - Respite Care and Home (PAM)

计划入组 106 人 · 首次发布于 2018 年 8 月 9 日

Tailored Therapy for Clarithromycin-Resistant H. Pylori

计划入组 782 人 · 首次发布于 2018 年 2 月 13 日

TRK-720

TRK-730

TRK-880

TRB CHEMEDICA

France

Pharma VAM

FAREVA PAU

France

AlzeCure's ACD856 Shows Promise with Anti-Inflammatory Effects in Alzheimer's Models

AlzeCure's ACD856 Alzheimer's Drug Receives EU Funding for Phase 2 Trial

AlzeCure Receives €2.5 Million EU Grant to Advance Phase 2a Trial of Novel Alzheimer's Drug ACD856